• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HER2阳性腋窝皮肤大汗腺癌的治疗

Treatment of HER2-positive cutaneous apocrine carcinoma of the axilla.

作者信息

Kamata Arimichi, Hino Koji, Matsuda Arisa, Kamiyama Koki, Takasaka Yoshihiro, Tazawa Kenichi

机构信息

Department of Breast Surgery, Tomei Atsugi Hospital, Atsugi, Kanagawa 232 Funako Japan.

Department of Pharmacy, Tomei Atsugi Hospital, Atsugi, Japan.

出版信息

Int Cancer Conf J. 2024 Jul 6;13(4):348-352. doi: 10.1007/s13691-024-00700-7. eCollection 2024 Oct.

DOI:10.1007/s13691-024-00700-7
PMID:39398928
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11464891/
Abstract

Cutaneous apocrine carcinoma (CAC) is an extremely rare skin appendage malignant tumor that develops in the apocrine sweat glands, and no evidence-based drug therapy has been established. A 61-year-old female patient was diagnosed with axillary CAC with axillary lymph node metastasis and underwent surgery. Pathological examination revealed seven lymph node metastases. Immunostaining revealed that the tumor cells were estrogen receptor (ER)-positive, progesterone receptor (PgR)-positive, and human epidermal growth factor receptor 2 (HER2)-positive. The patient received chemotherapy, including anti-HER2 drugs, and hormone therapy to prevent recurrence. No recurrence was observed for > 3 years after surgery. The apocrine glands in the skin and mammary glands have similar characteristics and mammary glands are thought to be modified or derived from the apocrine glands present in the subcutaneous adipose tissue. Therefore, ER, PgR, and HER2 levels may be positive in CAC. Drug treatments for breast cancer may also be effective for CAC.

摘要

皮肤大汗腺癌(CAC)是一种极其罕见的皮肤附属器恶性肿瘤,起源于大汗腺,目前尚未确立基于证据的药物治疗方法。一名61岁女性患者被诊断为伴有腋窝淋巴结转移的腋窝CAC并接受了手术。病理检查发现有7处淋巴结转移。免疫染色显示肿瘤细胞雌激素受体(ER)阳性、孕激素受体(PgR)阳性、人表皮生长因子受体2(HER2)阳性。该患者接受了包括抗HER2药物在内的化疗以及激素治疗以预防复发。术后超过3年未观察到复发。皮肤和乳腺中的大汗腺具有相似特征,并且认为乳腺是由皮下脂肪组织中存在的大汗腺演变或衍生而来。因此,CAC中ER、PgR和HER2水平可能为阳性。乳腺癌的药物治疗对CAC可能也有效。

相似文献

1
Treatment of HER2-positive cutaneous apocrine carcinoma of the axilla.HER2阳性腋窝皮肤大汗腺癌的治疗
Int Cancer Conf J. 2024 Jul 6;13(4):348-352. doi: 10.1007/s13691-024-00700-7. eCollection 2024 Oct.
2
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
3
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
4
Pure Apocrine Intraductal Carcinoma of Salivary Glands: Reassessment of Molecular Underpinnings and Behavior.涎腺纯大汗腺癌:分子基础和行为的再评估。
Head Neck Pathol. 2024 Jun 27;18(1):58. doi: 10.1007/s12105-024-01653-2.
5
Brain Metastases From HER2 Breast Cancer That Achieved Complete Response With Trastuzumab Deruxtecan Without Any Local Treatment.经曲妥珠单抗德鲁昔单抗治疗后达到完全缓解且未接受任何局部治疗的HER2阳性乳腺癌脑转移病例
Cureus. 2025 May 29;17(5):e85011. doi: 10.7759/cureus.85011. eCollection 2025 May.
6
Positron emission tomography (PET) and magnetic resonance imaging (MRI) for the assessment of axillary lymph node metastases in early breast cancer: systematic review and economic evaluation.正电子发射断层扫描(PET)和磁共振成像(MRI)在早期乳腺癌腋窝淋巴结转移评估中的应用:系统评价和经济评估。
Health Technol Assess. 2011 Jan;15(4):iii-iv, 1-134. doi: 10.3310/hta15040.
7
Axillary treatment for operable primary breast cancer.可手术原发性乳腺癌的腋窝治疗
Cochrane Database Syst Rev. 2017 Jan 4;1(1):CD004561. doi: 10.1002/14651858.CD004561.pub3.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.

引用本文的文献

1
Breast cancer histopathology, classification and clinical management: Current perspectives.乳腺癌组织病理学、分类及临床管理:当前观点
Bioinformation. 2024 Dec 31;20(12):2069-2079. doi: 10.6026/9732063002002069. eCollection 2024.

本文引用的文献

1
The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2022 edition.日本乳腺癌学会乳腺癌全身治疗临床实践指南,2022 年版。
Breast Cancer. 2023 Nov;30(6):872-884. doi: 10.1007/s12282-023-01505-x. Epub 2023 Oct 7.
2
Prognostic factors in cutaneous apocrine carcinoma: a single-institution retrospective study of 32 patients.皮肤顶泌汗腺癌的预后因素:单机构回顾性研究 32 例。
Int J Clin Oncol. 2023 Dec;28(12):1690-1696. doi: 10.1007/s10147-023-02420-z. Epub 2023 Oct 6.
3
Cutaneous Adnexal Adenocarcinoma: Genomic Analysis and Successful HER2-targeted Therapy of Metastatic Disease.皮肤附属器腺癌:转移性疾病的基因组分析及成功的HER2靶向治疗
Acta Derm Venereol. 2023 Aug 16;103:adv9399. doi: 10.2340/actadv.v103.9399.
4
[A Case of Apocrine Carcinoma in the Breast That Was Difficult to Distinguish from Axillary Apocrine Adenocarcinoma].[一例难以与腋窝大汗腺癌相鉴别的乳腺大汗腺癌病例]
Gan To Kagaku Ryoho. 2018 Dec;45(13):1961-1963.
5
Metastatic cutaneous apocrine carcinoma: a multidisciplinary approach incorporating endocrine therapy.转移性皮肤大汗腺癌:一种采用内分泌治疗的多学科方法
Eur J Dermatol. 2018 Jun 1;28(3):415-417. doi: 10.1684/ejd.2018.3282.
6
Metastatic Cutaneous Apocrine Adenocarcinoma Treated With a Combination of Pertuzumab-Based Targeted Therapy and Taxane Chemotherapy: A Case Report.采用帕妥珠单抗靶向治疗与紫杉烷化疗联合治疗转移性皮肤顶泌汗腺腺癌:一例报告
JAMA Dermatol. 2016 Jan;152(1):111-3. doi: 10.1001/jamadermatol.2015.2507.
7
Cutaneous and mammary apocrine carcinomas have different immunoprofiles.皮肤和乳腺大汗腺癌具有不同的免疫表型。
Hum Pathol. 2014 Feb;45(2):320-6. doi: 10.1016/j.humpath.2013.09.007. Epub 2013 Dec 14.
8
Treatment strategy for cutaneous apocrine carcinoma.皮肤大汗腺癌的治疗策略
Int J Clin Oncol. 2014 Aug;19(4):712-5. doi: 10.1007/s10147-013-0594-x. Epub 2013 Jul 31.
9
Case report: differential diagnosis between primary cutaneous apocrine adenocarcinoma versus extramammary or metastatic breast adenocarcinoma.病例报告:原发性皮肤大汗腺癌与乳腺外或转移性乳腺腺癌的鉴别诊断
Am J Dermatopathol. 2014 Oct;36(10):e175-8. doi: 10.1097/DAD.0b013e318288cdd2.
10
Advanced vulvar apocrine carcinoma expressing estrogen receptors that responds to tamoxifen therapy.高级外阴大汗腺癌表达雌激素受体,对他莫昔芬治疗有反应。
Future Oncol. 2012 Sep;8(9):1199-203. doi: 10.2217/fon.12.94.